A warm-start digital CRISPR/Cas-based method for the quantitative detection of nucleic acids

Anal Chim Acta. 2022 Mar 1:1196:339494. doi: 10.1016/j.aca.2022.339494. Epub 2022 Jan 25.

Abstract

Nucleic acids-based molecular diagnostic tools incorporating the CRISPR/Cas system are being developed as rapid and sensitive methods for pathogen detection. However, most CRISPR/Cas-based diagnostics lack quantitative detection ability. Here, we report Warm-Start RApid DIgital Crispr Approach (WS-RADICA) for the rapid, sensitive, and quantitative detection of nucleic acids. WS-RADICA detected as little as 1 copy/μl SARS-CoV-2 RNA in 40 min (qualitative detection) or 60 min (quantitative detection). WS-RADICA can be easily adapted to various digital devices: two digital chips were evaluated for both DNA and RNA quantification, with linear dynamic ranges of 0.8-12777 copies/μL for DNA and 1.2-18391 copies/μL for RNA (both R2 values > 0.99). Moreover, WS-RADICA had lower detection limit and higher inhibitor tolerance than a bulk RT-LAMP-Cas12b reaction and similar performance to RT-qPCR and RT-dPCR. To prove its performance on nucleic acids derived from live virus, WS-RADICA was also validated to detect and quantify human adenovirus and herpes simplex virus. Given its speed, sensitivity, quantification capability, and inhibitor tolerance, WS-RADICA shows great promise for a variety of applications requiring nucleic acid quantification.

Keywords: CRISPR/Cas; Isothermal amplification; Nucleic acids detection and quantification; Virus detection and quantification; Warmstart digital CRISPR.

MeSH terms

  • COVID-19*
  • CRISPR-Cas Systems / genetics
  • Humans
  • Nucleic Acid Amplification Techniques
  • Nucleic Acids*
  • RNA, Viral / genetics
  • SARS-CoV-2
  • Sensitivity and Specificity

Substances

  • Nucleic Acids
  • RNA, Viral